Importantly, as the high migration and invasion capacities presented in the melanoma can be suppressed by FADS2 inhibition in vitro and in vivo, inhibition of FADS2-mediated fatty acid desaturation offers a therapeutic opportunity to treat metastatic melanoma. The gene discussed is FADS2; the disease is melanoma.